Rhumbline Advisers ALEXION PHARMACEUTICALS CVR Transaction History

Rhumbline Advisers

  • $113 Billion
  • Q2 2025
Number of Shares
106,306
Previous 106,306 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
N/A
-577 Reduced 0.54%
106,306 $0
Q2 2024

Aug 01, 2024
SELL
N/A
-6,800 Reduced 5.98%
106,883 $0
Q2 2023

Aug 08, 2023
SELL
N/A
-190 Reduced 0.17%
113,683 $0
Q2 2021

Aug 05, 2021
SELL
N/A
-14,057 Reduced 10.99%
113,873 $0
Q1 2021

May 06, 2021
SELL
N/A
-64,065 Reduced 33.37%
127,930 $0
Q3 2020

Nov 12, 2020
SELL
N/A
-30,076 Reduced 13.54%
191,995 $0
Q1 2020

May 06, 2020
BUY
N/A
222,071 New
222,071 $0
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email